December 2025
1. FREEDMAN DO
   Asheville, North Carolina: The Origin of the American Tuberculosis Sanitarium Movement.
   Ann Intern Med. 2025 Dec 2. doi: 10.7326/ANNALS-25-02861.
   

   >> Share

   
   February 2025
2. LI Y, Marks SM, Beeler Asay GR, Winston CA, et al
   Effectiveness and Cost-Effectiveness of Expanded Targeted Testing and Treatment of Latent Tuberculosis Infection Among the Medicare Population in 2022.
   Ann Intern Med. 2025 Feb 7. doi: 10.7326/ANNALS-24-00870.
   

   >> Share

   
   
3. NACHMAN A, Chagla Z
   In rifampicin-resistant TB, bedaquiline-containing regimens reduced unfavorable status vs. a control regimen at 132 wk.
   Ann Intern Med. 2025;178:JC19.
   

   >> Share

   
   April 2024
4. LI Y, Regan M, Swartwood NA, Barham T, et al
   Disparities in Tuberculosis Incidence by Race and Ethnicity Among the U.S.-Born Population in the United States, 2011 to 2021 : An Analysis of National Disease Registry Data.
   Ann Intern Med. 2024 Apr 2. doi: 10.7326/M23-2975.
   

   >> Share

   
   
5. CASTRO KG, Shah NS
   Beyond the Bacillus: Closing Gaps in Tuberculosis Health Disparities Requires Targeting Social Determinants.
   Ann Intern Med. 2024 Apr 2. doi: 10.7326/M24-0548.
   

   >> Share

   
   June 2023
6. SACKS HS
   In TB, an 8-wk, 5-drug regimen was noninferior to a standard 24-wk, 4-drug regimen for clinical outcomes at 96 wk.
   Ann Intern Med. 2023;176:JC64.
   

   >> Share

   
   March 2023
7. CONTAG CA, Maloney N, Tayyar R, Aleshin MA, et al
   Erythema Gyratum Repens Secondary to Pulmonary Tuberculosis.
   Ann Intern Med. 2023 Mar 14. doi: 10.7326/L22-0453.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share